A novel immunotherapy could lead to a brain cancer breakthrough after showing promising results against glioblastoma, the ...

A type of immunotherapy has shown promising results in targeting the deadliest type of brain cancer, researchers say.

A study led by a researcher based at King's College London and McMaster University in Canada reveals how CAR-T cell therapy, a treatment that engineers a patient's own immune cells to recognize and ...

Glioblastoma multiforme (GBM), the most common type of malignant brain tumor, has a very high mortality rate, due in part to ...

Summary: Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of liquid blood cancers by engineering a patient’s own immune cells to destroy malignant targets, replicating ...

NewYork-Presbyterian's GLICO seeks to overcome glioblastoma's resistance by mimicking brain environments to test treatments ...

Researchers have identified a vitamin B12–based compound that can cross the blood-brain barrier and home in on glioblastoma tumors. In animal studies, the compound accumulated preferentially in tumor ...

One of the most aggressive and challenging types of brain cancer to treat is still glioblastoma. The majority of patients ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. While rare, malignant brain tumors often have poor outcomes Nearly half of all malignant ...

After her husband's glioblastoma diagnosis, Kim Busch returned to the all-female California winery she'd walked away from and turned it into a fund for the costs cancer families don't see coming.